WO2001030397A3 - Ultrasound inducement of artial and ventricular rhythms - Google Patents
Ultrasound inducement of artial and ventricular rhythms Download PDFInfo
- Publication number
- WO2001030397A3 WO2001030397A3 PCT/US2000/041501 US0041501W WO0130397A3 WO 2001030397 A3 WO2001030397 A3 WO 2001030397A3 US 0041501 W US0041501 W US 0041501W WO 0130397 A3 WO0130397 A3 WO 0130397A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patients
- ultrasound
- artial
- inducement
- ventricular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
- A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU24691/01A AU2469101A (en) | 1999-10-25 | 2000-10-24 | Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/426,378 | 1999-10-25 | ||
US09/426,378 US6439236B1 (en) | 1999-10-25 | 1999-10-25 | Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001030397A2 WO2001030397A2 (en) | 2001-05-03 |
WO2001030397A3 true WO2001030397A3 (en) | 2002-07-11 |
Family
ID=23690556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/041501 WO2001030397A2 (en) | 1999-10-25 | 2000-10-24 | Ultrasound inducement of artial and ventricular rhythms |
Country Status (3)
Country | Link |
---|---|
US (1) | US6439236B1 (en) |
AU (1) | AU2469101A (en) |
WO (1) | WO2001030397A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL148299A (en) * | 2002-02-21 | 2014-04-30 | Technion Res & Dev Foundation | Ultrasound cardiac stimulator |
CA2442352A1 (en) * | 2002-09-26 | 2004-03-26 | Reg Macquarrie | Poly-(vinyl alcohol) based meat processing films |
EP1572001A1 (en) * | 2002-11-29 | 2005-09-14 | Amersham Health AS | Ultrasound triggering method |
US7006864B2 (en) * | 2003-06-17 | 2006-02-28 | Ebr Systems, Inc. | Methods and systems for vibrational treatment of cardiac arrhythmias |
US7184830B2 (en) * | 2003-08-18 | 2007-02-27 | Ebr Systems, Inc. | Methods and systems for treating arrhythmias using a combination of vibrational and electrical energy |
US7050849B2 (en) * | 2003-11-06 | 2006-05-23 | Ebr Systems, Inc. | Vibrational therapy device used for resynchronization pacing in a treatment for heart failure |
US7025726B2 (en) * | 2004-01-22 | 2006-04-11 | The Regents Of The University Of Nebraska | Detection of endothelial dysfunction by ultrasonic imaging |
US7765001B2 (en) | 2005-08-31 | 2010-07-27 | Ebr Systems, Inc. | Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
EP1833553B1 (en) | 2004-12-21 | 2015-11-18 | EBR Systems, Inc. | Implantable transducer devices |
JP5111116B2 (en) * | 2004-12-21 | 2012-12-26 | イービーアール システムズ, インコーポレイテッド | Leadless cardiac system for pacing and arrhythmia treatment |
US7558631B2 (en) * | 2004-12-21 | 2009-07-07 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US7702392B2 (en) * | 2005-09-12 | 2010-04-20 | Ebr Systems, Inc. | Methods and apparatus for determining cardiac stimulation sites using hemodynamic data |
US8718773B2 (en) * | 2007-05-23 | 2014-05-06 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
US7953493B2 (en) | 2007-12-27 | 2011-05-31 | Ebr Systems, Inc. | Optimizing size of implantable medical devices by isolating the power source |
EP2265166B1 (en) | 2008-03-25 | 2020-08-05 | EBR Systems, Inc. | Temporary electrode connection for wireless pacing systems |
US20100016911A1 (en) | 2008-07-16 | 2010-01-21 | Ebr Systems, Inc. | Local Lead To Improve Energy Efficiency In Implantable Wireless Acoustic Stimulators |
US9931048B2 (en) | 2013-04-30 | 2018-04-03 | Medtronic, Inc. | Systems, methods, and interfaces for identifying effective electrodes |
US9986928B2 (en) | 2013-12-09 | 2018-06-05 | Medtronic, Inc. | Noninvasive cardiac therapy evaluation |
US11253178B2 (en) | 2015-01-29 | 2022-02-22 | Medtronic, Inc. | Noninvasive assessment of cardiac resynchronization therapy |
US11219769B2 (en) | 2016-02-26 | 2022-01-11 | Medtronic, Inc. | Noninvasive methods and systems of determining the extent of tissue capture from cardiac pacing |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4718433A (en) * | 1983-01-27 | 1988-01-12 | Feinstein Steven B | Contrast agents for ultrasonic imaging |
WO1999061058A1 (en) * | 1998-05-23 | 1999-12-02 | Quadrant Healthcare (Uk) Limited | Method of altering heartbeat |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5449926A (en) | 1977-09-28 | 1979-04-19 | Hitachi Ltd | Method of making mold |
US4572203A (en) | 1983-01-27 | 1986-02-25 | Feinstein Steven B | Contact agents for ultrasonic imaging |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
EP0504881B2 (en) | 1991-03-22 | 2000-11-08 | Katsuro Tachibana | Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same |
HU218018B (en) | 1991-09-17 | 2000-05-28 | Sonus Pharmaceuticals Inc. | Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
US5567415A (en) * | 1993-05-12 | 1996-10-22 | The Board Of Regents Of The University Of Nebraska | Ultrasound contrast agents and methods for their manufacture and use |
US5695740A (en) * | 1993-05-12 | 1997-12-09 | The Board Of Regents Of The University Of Nebraska | Perfluorocarbon ultrasound contrast agent comprising microbubbles containing a filmogenic protein and a saccharide |
US5701899A (en) * | 1993-05-12 | 1997-12-30 | The Board Of Regents Of The University Of Nebraska | Perfluorobutane ultrasound contrast agent and methods for its manufacture and use |
NO940711D0 (en) | 1994-03-01 | 1994-03-01 | Nycomed Imaging As | Preparation of gas-filled microcapsules and contrast agents for diagnostic imaging |
US5560364A (en) * | 1995-05-12 | 1996-10-01 | The Board Of Regents Of The University Of Nebraska | Suspended ultra-sound induced microbubble cavitation imaging |
US6139819A (en) * | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6231834B1 (en) * | 1995-06-07 | 2001-05-15 | Imarx Pharmaceutical Corp. | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
IT1291182B1 (en) * | 1997-03-12 | 1998-12-29 | Gevipi Ag | CARTRIDGE FOR TAP WITH FLOOR ORGAN |
-
1999
- 1999-10-25 US US09/426,378 patent/US6439236B1/en not_active Expired - Fee Related
-
2000
- 2000-10-24 WO PCT/US2000/041501 patent/WO2001030397A2/en active Application Filing
- 2000-10-24 AU AU24691/01A patent/AU2469101A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4718433A (en) * | 1983-01-27 | 1988-01-12 | Feinstein Steven B | Contrast agents for ultrasonic imaging |
WO1999061058A1 (en) * | 1998-05-23 | 1999-12-02 | Quadrant Healthcare (Uk) Limited | Method of altering heartbeat |
Non-Patent Citations (3)
Title |
---|
PORTER, THOMAS R. (1) ET AL: "Transthoracic ultrasound and microbubble induced atrial and ventricular arrhythmias: Incidence and potential mechanisms.", CIRCULATION, (NOV. 2, 1999) VOL. 110, NO. 18 SUPPL., PP. I.445. MEETING INFO.: 72ND SCIENTIFIC SESSIONS OF THE AMERICAN HEART ASSOCIATION ATLANTA, GEORGIA, USA NOVEMBER 7-10, 1999, XP001041772 * |
PORTER, THOMAS R. ET AL: "Myocardial perfusion abnormalities during low-dose dobutamine after coronary reperfusion can be demonstrated with intravenous perfluorocarbon-exposed sonicated dextrose albumin ultrasound contrast", AM. HEART J. (1996), 131(6), 1079-1087, XP001041774 * |
PORTER, THOMAS R. ET AL: "Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases", J. AM. COLL. CARDIOL. (1995), 25(2), 509-15, XP001041775 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001030397A2 (en) | 2001-05-03 |
US6439236B1 (en) | 2002-08-27 |
AU2469101A (en) | 2001-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001030397A3 (en) | Ultrasound inducement of artial and ventricular rhythms | |
DE50014770D1 (en) | ELECTRODE CATHETER WITH REDUCED STORAGE ACTIVITY AND SAME ELECTRODE SURFACE TREATMENT METHOD | |
WO2002051495A3 (en) | Pacing methods and devices for treating cardiac arrhythmias and fibrillation | |
Schuder et al. | Defibrillation of 100 kg calves with asymmetrical, bidirectional, rectangular pulses | |
DE60139077D1 (en) | SYSTEM FOR ENDOTRACHEAL / ESPHAGIC STIMULATION BEFORE AND DURING A MEDICAL PROCEDURE | |
Sweeney | Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:. | |
DE69917758D1 (en) | DEVICE FOR TREATING Atrial Arrhythmias | |
WO2001010496A3 (en) | Method and apparatus for waveform output | |
WO2005000398A3 (en) | Intravascular electrophysiological system and methods | |
WO2002034330A3 (en) | Method and apparatus to minimize the effects of a cardiac insult | |
CA2171108A1 (en) | Waveform Discriminator for Cardiac Stimulation Devices | |
WO2002045791A3 (en) | Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac comditions | |
WO2004062479A3 (en) | Non-invasive heart treatment device | |
EP1114653A3 (en) | An implantable cardioversion device with a self-adjusting threshold for therapy selection | |
WO2002003872A3 (en) | Application of photochemotherapy for the treatment of cardiac arrhythmias | |
WO2002019966A3 (en) | Cardiac arrhythmia treatment methods | |
FR2763247B1 (en) | ACTIVE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR A CARDIAC STIMULATOR, DEFIBRILLATOR AND / OR CARDIOVERTER FOR REDUCING ARRHYTHMIA EPISODES, ESPECIALLY ATRIAL ARRHYTHMIA | |
CA2242356A1 (en) | Methods and apparatus for myocardial revascularization | |
DE60026121D1 (en) | An implantable ventricular cardioverter / defibrillator with atrial pacing to prevent ventricular cardioversion and defibrillation shocks from producing atrial fibrillation | |
CA2250420A1 (en) | Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest | |
WO2004098706A3 (en) | History-dependent pacing interval determination for antitachycardia pacing | |
WO2009108810A3 (en) | Apparatus and method for treating atrial fibrillation and atrial tachycardia | |
WO2001058518A8 (en) | Cardiac control using paired pacing | |
ATE305325T1 (en) | ACTIVE MEDICAL DEVICE OF IMPLANTABLE DEFIBRILLATOR/CARDIOVERTER TYPE WITH IMPROVED DISTINCTION FROM Atrial FIBRILLATION | |
Walcott et al. | Biphasic waveform external defibrillation thresholds for spontaneous ventricular fibrillation secondary to acute ischemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |